Annual Working Capital
$81.24 M
-$19.45 M-19.32%
December 31, 2023
Summary
- As of February 8, 2025, IMRX annual working capital is $81.24 million, with the most recent change of -$19.45 million (-19.32%) on December 31, 2023.
- During the last 3 years, IMRX annual working capital has risen by +$45.76 million (+129.00%).
- IMRX annual working capital is now -44.62% below its all-time high of $146.70 million, reached on December 31, 2021.
Performance
IMRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$48.34 M
-$8.57 M-15.05%
September 30, 2024
Summary
- As of February 8, 2025, IMRX quarterly working capital is $48.34 million, with the most recent change of -$8.57 million (-15.05%) on September 30, 2024.
- Over the past year, IMRX quarterly working capital has dropped by -$20.93 million (-30.22%).
- IMRX quarterly working capital is now -67.35% below its all-time high of $148.04 million, reached on September 30, 2021.
Performance
IMRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IMRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -30.2% |
| 3 y3 years | +129.0% | -52.0% |
| 5 y5 years | +499.2% | -52.0% |
IMRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.6% | at low | -67.0% | at low |
| 5 y | 5-year | -44.6% | +499.2% | -67.3% | +64.3% |
| alltime | all time | -44.6% | +499.2% | -67.3% | +64.3% |
Immuneering Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $48.34 M(-15.1%) |
| Jun 2024 | - | $56.90 M(-17.9%) |
| Mar 2024 | - | $69.27 M(-14.7%) |
| Dec 2023 | $81.24 M(-19.3%) | $81.24 M(-14.5%) |
| Sep 2023 | - | $94.96 M(-10.4%) |
| Jun 2023 | - | $106.03 M(+19.5%) |
| Mar 2023 | - | $88.71 M(-11.9%) |
| Dec 2022 | $100.69 M | $100.69 M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $112.77 M(-10.1%) |
| Jun 2022 | - | $125.37 M(-7.7%) |
| Mar 2022 | - | $135.86 M(-7.4%) |
| Dec 2021 | $146.70 M(+313.5%) | $146.70 M(-0.9%) |
| Sep 2021 | - | $148.04 M(+217.7%) |
| Jun 2021 | - | $46.60 M(+58.4%) |
| Mar 2021 | - | $29.42 M(-17.1%) |
| Dec 2020 | $35.48 M(+161.7%) | $35.48 M |
| Dec 2019 | $13.56 M | - |
FAQ
- What is Immuneering annual working capital?
- What is the all time high annual working capital for Immuneering?
- What is Immuneering annual working capital year-on-year change?
- What is Immuneering quarterly working capital?
- What is the all time high quarterly working capital for Immuneering?
- What is Immuneering quarterly working capital year-on-year change?
What is Immuneering annual working capital?
The current annual working capital of IMRX is $81.24 M
What is the all time high annual working capital for Immuneering?
Immuneering all-time high annual working capital is $146.70 M
What is Immuneering annual working capital year-on-year change?
Over the past year, IMRX annual working capital has changed by -$19.45 M (-19.32%)
What is Immuneering quarterly working capital?
The current quarterly working capital of IMRX is $48.34 M
What is the all time high quarterly working capital for Immuneering?
Immuneering all-time high quarterly working capital is $148.04 M
What is Immuneering quarterly working capital year-on-year change?
Over the past year, IMRX quarterly working capital has changed by -$20.93 M (-30.22%)